Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever

K-Number: K203219 · 2020-12-29

Decision Date2020-12-29
Product CodePOL
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is a medical device manufactured by Stryker Neurovascular. It received FDA 510(k) clearance on 2020-12-29 under approval number K203219. The device is classified under product code POL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever?

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is a medical device that received FDA 510(k) clearance on 2020-12-29. It is manufactured by Stryker Neurovascular. The 510(k) number is K203219.

When was Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever approved by the FDA?

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever received FDA 510(k) clearance on 2020-12-29, under approval number K203219.

What company makes Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever?

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is manufactured by Stryker Neurovascular.

What is the FDA product code for Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever?

The FDA product code for Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is POL.

Related Clinical Trials

Other Devices by Stryker Neurovascular

View all 26 devices →

Related Devices (Code: POL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.